Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zenon Biosystem
Valencia, Spain
- Ownership
- Private
- Development stage
- Other
01
Overview
Zenon Biosystem is a contracted development partner for Zenosense, Inc., working on detection devices for MRSA and lung cancer using volatile organic compound (VOC) analysis technology. The company has developed technical protocols using Gas Chromatography/Mass Spectrometry and Surface Acoustic Wave polymer sensors, with initial testing showing sensitivity and specificity up to 75% and 66% respectively.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Device
- Industry
- Metabolite Diagnostics
02
Partnerships
Zenosense, Inc. (development partner relationship)hospitalsuniversitiesprivate laboratories (in sensor technology, polymer electrochemistry, microbiology, and infectious disease)
Beyond the preview
Go deeper on Zenon Biosystem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zenon Biosystem.